Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity

John Wehry, Steven Agle, Prejesh Philips, Robert Cannon, Charles R. Scoggins, Lisa Puffer, Kelly M. McMasters, Robert C G Martin

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Background The purpose of this study was to determine the impact of a restrictive blood transfusion protocol on the number of transfusions performed and the related effect on patient morbidity. Methods A cohort study was performed using our prospective database with information from January 1, 2000, to June 1, 2013. The restrictive blood transfusion protocol was implemented in September 2011, so this date served as the separation point for the date of operation criteria. Results For the study, 415 patients undergoing operation for an abdominal malignancy were reviewed. After the restrictive blood transfusion protocol, the percentage of patients who received blood dropped from 35.6% to 28.3%. The percentage of patients who experienced perioperative complication was significantly higher in transfused patients compared with those who did not receive blood (P =.0001). There was no statistical significance observed between the 5 groups for the length of stay at the hospital after their procedure. Conclusions The restrictive blood transfusion protocol resulted in a reduction of the percentage of patients transfused, and there was no evidence to suggest that it negatively affected the outcomes of patients in this group.

Original languageEnglish (US)
Pages (from-to)1197-1205
Number of pages9
JournalAmerican Journal of Surgery
Volume210
Issue number6
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Keywords

  • Blood transfusion
  • Complications
  • Esophagectomy
  • Gastrectomy
  • Hepatectomy
  • Pancreatectomy

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity'. Together they form a unique fingerprint.

  • Cite this